• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对具有生理极限的基本间接药效学反应模型的评估。

Assessment of basic indirect pharmacodynamic response models with physiological limits.

作者信息

Yao Zhenling, Krzyzanski Wojciech, Jusko William J

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York, Buffalo, NY 14260, USA.

出版信息

J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):167-93. doi: 10.1007/s10928-006-9003-7.

DOI:10.1007/s10928-006-9003-7
PMID:16547797
Abstract

Many physiological factors are regulated by homeostatic mechanisms to maintain normal body function. Empirical lower Rl (Model I and IV) or upper Rh limits (Model II and III) were included in current basic indirect response (IDR) models to account for the additional role of physiological limits (IDRPL). Various characteristics of these models were evaluated with simulations and explicit equations. The simulations reveal that the expanded models exhibit most properties of basic indirect response models, such as slow response initiation, lag time between the kinetic and dynamic peaks, a large dose plateau, and shift in Tmax with dose. The proposed models always produce lesser net responses than predicted by basic IDR models. Simulations demonstrate that addition of a parameter limit which is close to the baseline has a great influence on the overall and maximum responses and fitted model parameters. Only stimulatory IDRPL Models III and IV allow resolution of all model parameters in the absence of clear indications or predetermined values of the lower or upper limits. However, all four models are able to resolve model parameters when subgroups with different baselines are simultaneously fitted. These models create new interpretations of the determinants of baseline conditions which can be important in assessing inter-subject variability in responses. The applicability of IDRPL models is demonstrated using several examples from the published literature. Indirect response models with physiological limits will be useful in characterizing drug responses for turnover systems which are maintained within a certain range.

摘要

许多生理因素通过稳态机制进行调节,以维持身体的正常功能。当前的基本间接响应(IDR)模型纳入了经验性的较低Rl(模型I和IV)或较高Rh限值(模型II和III),以解释生理限值(IDRPL)的额外作用。通过模拟和显式方程对这些模型的各种特性进行了评估。模拟结果表明,扩展后的模型展现出基本间接响应模型的大多数特性,如响应起始缓慢、动力学峰值与动态峰值之间的滞后时间、大剂量平台以及Tmax随剂量的变化。所提出的模型产生的净响应总是低于基本IDR模型的预测值。模拟表明,添加一个接近基线的参数限值对总体和最大响应以及拟合模型参数有很大影响。只有刺激性的IDRPL模型III和IV在没有下限或上限的明确指示或预定值的情况下能够解析所有模型参数。然而,当同时拟合具有不同基线的亚组时,所有四个模型都能够解析模型参数。这些模型对基线条件的决定因素产生了新的解释,这在评估受试者间反应变异性方面可能很重要。通过已发表文献中的几个例子展示了IDRPL模型的适用性。具有生理限值的间接响应模型将有助于表征维持在一定范围内的周转系统的药物反应。

相似文献

1
Assessment of basic indirect pharmacodynamic response models with physiological limits.对具有生理极限的基本间接药效学反应模型的评估。
J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):167-93. doi: 10.1007/s10928-006-9003-7.
2
Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes.
Clin Pharmacol Ther. 1995 Dec;58(6):631-40. doi: 10.1016/0009-9236(95)90019-5.
3
Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.评估给药对基本间接反应模型参数估计中个体内变异性的影响。
J Pharmacokinet Pharmacodyn. 2006 Oct;33(5):635-55. doi: 10.1007/s10928-006-9028-y. Epub 2006 Aug 29.
4
Feedback control indirect response models.反馈控制间接响应模型。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):343-58. doi: 10.1007/s10928-016-9479-8. Epub 2016 Jul 9.
5
Role of dosage regimen in controlling indirect pharmacodynamic responses.给药方案在控制间接药效学反应中的作用。
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):45-57. doi: 10.1016/s0169-409x(00)00132-0.
6
Pharmacodynamic models of age-structured cell populations.年龄结构细胞群体的药效学模型。
J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):573-89. doi: 10.1007/s10928-015-9446-9. Epub 2015 Sep 16.
7
Assessment of drug interactions relevant to pharmacodynamic indirect response models.与药效学间接反应模型相关的药物相互作用评估。
J Pharmacokinet Pharmacodyn. 2004 Oct;31(5):345-80. doi: 10.1007/s10928-004-8319-4.
8
Pharmacodynamic Models of Indirect Effects and Irreversible Inactivation with Turnover: Applicability to Mechanism-Based Modeling of Gene Silencing and Targeted Protein Degradation.具有转化的间接效应和不可逆失活的药效动力学模型:对基因沉默和靶向蛋白降解的基于机制建模的适用性。
J Pharm Sci. 2024 Jan;113(1):191-201. doi: 10.1016/j.xphs.2023.10.027. Epub 2023 Oct 25.
9
(2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.(2-苄基-2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚-8-基)乙酸:一种醛糖还原酶抑制剂和两性离子抗氧化剂。
Bioorg Med Chem. 2011 Dec 1;19(23):7181-5. doi: 10.1016/j.bmc.2011.09.053. Epub 2011 Oct 4.
10
Methods of utilizing baseline values for indirect response models.利用基线值的间接反应模型方法。
J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):381-405. doi: 10.1007/s10928-009-9128-6. Epub 2009 Aug 21.

引用本文的文献

1
Breadth of Pharmacology Modeling: Fundamentals of Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling.
Handb Exp Pharmacol. 2025;289:21-73. doi: 10.1007/164_2025_746.
2
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.从基础到系统药效动力学模型的转变:皮质类固醇的经验教训。
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
3
Quantitative Systems Pharmacology: A Framework for Context.定量系统药理学:一种情境框架。

本文引用的文献

1
Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses.新型非甾体5α-还原酶抑制剂TF-505在单剂量或多剂量治疗的正常受试者中的药代动力学和药效学
Br J Clin Pharmacol. 2002 Sep;54(3):283-94. doi: 10.1046/j.1365-2125.2002.01656.x.
2
Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.皮质类固醇药效学的第五代模型:在大鼠中连续七天输注甲泼尼龙期间应用于稳态受体下调和酶诱导模式。
J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):1-24. doi: 10.1023/a:1015765201129.
3
Curr Pharmacol Rep. 2016 Jun;2(3):152-160. doi: 10.1007/s40495-016-0058-x. Epub 2016 Apr 8.
4
Exposure-response modelling for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂恩格列净在2型糖尿病患者中的暴露-反应模型构建
Br J Clin Pharmacol. 2014 Dec;78(6):1407-18. doi: 10.1111/bcp.12453.
5
Quantitative Systems Pharmacology Model of NO Metabolome and Methemoglobin Following Long-Term Infusion of Sodium Nitrite in Humans.人类长期输注亚硝酸钠后一氧化氮代谢组学和高铁血红蛋白的定量系统药理学模型。
CPT Pharmacometrics Syst Pharmacol. 2013 Jul 31;2(7):e60. doi: 10.1038/psp.2013.35.
6
Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acid.多次静脉输注烟酸后大鼠非酯化脂肪酸的周转模型
Dose Response. 2009 Apr 8;7(3):247-69. doi: 10.2203/dose-response.08-028.Isaksson.
7
Methods of utilizing baseline values for indirect response models.利用基线值的间接反应模型方法。
J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):381-405. doi: 10.1007/s10928-009-9128-6. Epub 2009 Aug 21.
Asymptotics of the total net direct pharmacological effect for large drug doses.
大剂量药物的总净直接药理效应的渐近性。
J Math Biol. 2000 Dec;41(6):477-92. doi: 10.1007/s002850000052.
4
Basic pharmacodynamic models for agents that alter production of natural cells.用于改变天然细胞生成的药物的基本药效学模型。
J Pharmacokinet Biopharm. 1999 Oct;27(5):467-89. doi: 10.1023/a:1023249813106.
5
Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods.使用间接响应模型对昼夜皮质醇浓度进行数学建模:几种方法的比较。
J Pharmacokinet Biopharm. 1999 Feb;27(1):23-43. doi: 10.1023/a:1020678628317.
6
Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.用于耐受性和反跳现象的前体依赖间接药效学反应模型。
J Pharm Sci. 1998 Dec;87(12):1577-84. doi: 10.1021/js980171q.
7
Interchangeability and predictive performance of empirical tolerance models.经验性耐受模型的互换性和预测性能。
Clin Pharmacokinet. 1999 Feb;36(2):145-67. doi: 10.2165/00003088-199936020-00005.
8
Integrated functions for four basic models of indirect pharmacodynamic response.间接药效学反应四种基本模型的综合函数。
J Pharm Sci. 1998 Jan;87(1):67-72. doi: 10.1021/js970168r.
9
Characterization of four basic models of indirect pharmacodynamic responses.四种间接药效学反应基本模型的表征
J Pharmacokinet Biopharm. 1996 Dec;24(6):611-35. doi: 10.1007/BF02353483.
10
Application of moment analysis to the sigmoid effect model for drug administered intravenously.矩分析在静脉注射给药的S形效应模型中的应用。
Pharm Res. 1997 Jul;14(7):949-52. doi: 10.1023/a:1012120421395.